By Emma Thomasson ZURICH, Aug 27 (Reuters) - Swiss drugmaker Roche Holding AG said its "armed antibody" T-DM1 drug significantly extend...
Read Whole Story
A new drug called T-DM1 appears to be relatively effective and safe for women with metastatic, Her2+ breast cancer, in itself and as compared to the standard XL regimen.
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.